Cargando…
Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease
BACKGROUND: Gaucher disease is an inherited lysosomal storage disorder of which there are three subtypes. Type 1 disease has no neurological involvement and is treatable with enzyme replacement therapy. Type 2 disease results in infant death and type 3 disease is a heterogenous disorder characterise...
Autores principales: | Donald, Aimee, Cizer, Huseyin, Finnegan, Niamh, Collin-Histed, Tanya, Hughes, Derralynn A., Davies, Elin Haf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727397/ https://www.ncbi.nlm.nih.gov/pubmed/31488169 http://dx.doi.org/10.1186/s13023-019-1182-6 |
Ejemplares similares
-
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative
por: Collin-Histed, Tanya, et al.
Publicado: (2023) -
The definition of neuronopathic Gaucher disease
por: Schiffmann, Raphael, et al.
Publicado: (2020) -
Understanding patient and parent/caregiver perceptions on gene therapy in Gaucher disease: an international survey
por: Collin-Histed, Tanya, et al.
Publicado: (2023) -
In-depth phenotyping for clinical stratification of Gaucher disease
por: D’Amore, Simona, et al.
Publicado: (2021) -
The European Gaucher Alliance: a survey of member patient organisations’ activities, healthcare environments and concerns
por: Žnidar, Irena, et al.
Publicado: (2014)